Home LiteratureArticle Details
PMID: 11390614 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

p21cip1 Degradation in differentiated keratinocytes is abrogated by costabilization with cyclin E induced by human papillomavirus E7.

Journal of virology ·Vol. 75 ·No. 13 ·2001-07-00 ·Pages 6121-34

Noya F, Chien WM, Broker TR, Chow LT

Abstract

The human papillomavirus (HPV) E7 protein promotes S-phase reentry in a fraction of postmitotic, differentiated keratinocytes. Here we report that these cells contain an inherent mechanism that opposes E7-induced DNA replication. In organotypic raft cultures of primary human keratinocytes, neither cyclin E nor p21cip1 is detectable in situ. However, E7-transduced differentiated cells not in S phase accumulate abundant cyclin E and p21cip1. We show that normally p21cip1 protein is rapidly degraded by proteasomes. In the presence of E7 or E6/E7, p21cip1, cyclin E, and cyclin E2 proteins were all up-regulated. The accumulation of p21cip1 protein is a posttranscriptional event, and ectopic cyclin E expression was sufficient to trigger it. In constract, cdk2 and p27kip1 were abundant in normal differentiated cells and were not significantly affected by E7. Cyclin E, cdk2, and p21cip1 or p27kip1 formed complexes, and relatively little kinase activity was found associated with cyclin E or cdk2. In patient papillomas and E7 raft cultures, all p27kip1-positive cells were negative for bromodeoxyuridine (BrdU) incorporation, but only some also contained cyclin E and p21cip1. In contrast, all cyclin E-positive cells also contained p27kip1. When the expression of p21cip1 was reduced by rottlerin, a PKC delta inhibitor, p27kip1- and BrdU-positive cells remained unchanged. These observations show that high levels of endogenous p27kip1 can prevent E7-induced S-phase reentry. This inhibition then leads to the stabilization of cyclin E and p21cip1. Since efficient initiation of viral DNA replication requires cyclin E and cdk2, its inhibition accounts for heterogeneous viral activities in productively infected lesions.

MeSH Terms
Acetophenones/pharmacology Acetylcysteine/analogs & derivatives,pharmacology Animals Benzopyrans/pharmacology Cyclin E/analysis,physiology Cyclin-Dependent Kinase Inhibitor p21 Cyclins/analysis,chemistry,metabolism Cysteine Endopeptidases/physiology DNA-Binding Proteins Humans Infant, Newborn Keratinocytes/metabolism Multienzyme Complexes/physiology Oncogene Proteins, Viral/physiology Proteasome Endopeptidase Complex Protein Kinase C/physiology Rabbits
Chemicals
Acetophenones Benzopyrans CDKN1A protein, human Cyclin E Cyclin-Dependent Kinase Inhibitor p21 Cyclins DNA-Binding Proteins E7 protein, Human papillomavirus type 18 Multienzyme Complexes Oncogene Proteins, Viral lactacystin rottlerin Protein Kinase C Cysteine Endopeptidases Proteasome Endopeptidase Complex Acetylcysteine
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Noya F
Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294-0005, USA.
Chien W M
Broker T R
Chow L T
References (81)
81 references, click to expand
  1. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes.
    Genes Dev. 1995 Oct 1;9(19):2335-49 PMID: 7557386
  2. Regulation of the cyclin E gene by transcription factor E2F1.
    Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12146-50 PMID: 8618861
  3. Regulation of p21WAF1/CIP1 expression by p53-independent pathways.
    Oncogene. 1996 Apr 4;12(7):1557-64 PMID: 8622872
  4. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein.
    Oncogene. 1996 Mar 21;12(6):1173-80 PMID: 8649818
  5. Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers.
    Mol Cell Biol. 1999 Jan;19(1):612-22 PMID: 9858585
  6. Cell cycle-dependent regulation of human DNA polymerase alpha-primase activity by phosphorylation.
    Mol Cell Biol. 1999 Jan;19(1):646-56 PMID: 9858588
  7. Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1).
    Genes Dev. 1998 Dec 15;12(24):3882-8 PMID: 9869641
  8. Cell-free degradation of p27(kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome.
    Mol Cell Biol. 1999 Feb;19(2):1190-201 PMID: 9891053
  9. Interaction between cyclin-dependent kinases and human papillomavirus replication-initiation protein E1 is required for efficient viral replication.
    Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):382-7 PMID: 9892642
  10. Concordant induction of cyclin E and p21cip1 in differentiated keratinocytes by the human papillomavirus E7 protein inhibits cellular and viral DNA synthesis.
    Cell Growth Differ. 1999 Feb;10(2):101-11 PMID: 10074904
  11. Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing.
    J Biol Chem. 1999 May 14;274(20):13886-93 PMID: 10318797
  12. Overriding of cyclin-dependent kinase inhibitors by high and low risk human papillomavirus types: evidence for an in vivo role in cervical lesions.
    Oncogene. 1999 Apr 1;18(13):2201-11 PMID: 10327066
  13. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation.
    Genes Dev. 1999 May 1;13(9):1181-9 PMID: 10323868
  14. Collaborative role of E2F transcriptional activity and G1 cyclindependent kinase activity in the induction of S phase.
    Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6626-31 PMID: 10359762
  15. CDK inhibitors: positive and negative regulators of G1-phase progression.
    Genes Dev. 1999 Jun 15;13(12):1501-12 PMID: 10385618
  16. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1.
    Cell. 1999 Sep 17;98(6):859-69 PMID: 10499802
  17. Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells.
    Genes Dev. 1999 Sep 15;13(18):2375-87 PMID: 10500095
  18. Culprits in the degradation of cyclin E apprehended.
    Genes Dev. 1999 Nov 1;13(21):2751-7 PMID: 10557204
  19. Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity.
    J Virol. 1997 Jul;71(7):5570-8 PMID: 9188631
  20. Cyclin E-CDK2 is a regulator of p27Kip1.
    Genes Dev. 1997 Jun 1;11(11):1464-78 PMID: 9192873
  21. Cyclin E-induced S phase without activation of the pRb/E2F pathway.
    Genes Dev. 1997 Jun 1;11(11):1479-92 PMID: 9192874
  22. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.
    Cell. 1996 May 31;85(5):707-20 PMID: 8646779
  23. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).
    Cell. 1996 May 31;85(5):721-32 PMID: 8646780
  24. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice.
    Cell. 1996 May 31;85(5):733-44 PMID: 8646781
  25. An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective.
    Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6687-92 PMID: 8692879
  26. Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein.
    Oncogene. 1996 Dec 5;13(11):2323-30 PMID: 8957073
  27. Protein kinase C isozyme-mediated cell cycle arrest involves induction of p21(waf1/cip1) and p27(kip1) and hypophosphorylation of the retinoblastoma protein in intestinal epithelial cells.
    J Biol Chem. 1997 Apr 4;272(14):9424-35 PMID: 9083081
  28. Cyclin-dependent kinase and initiation at eukaryotic origins: a replication switch?
    Curr Opin Cell Biol. 1997 Jun;9(3):358-63 PMID: 9159077
  29. Retinoblastoma protein represses transcription by recruiting a histone deacetylase.
    Nature. 1998 Feb 5;391(6667):601-5 PMID: 9468140
  30. Rb interacts with histone deacetylase to repress transcription.
    Cell. 1998 Feb 20;92(4):463-73 PMID: 9491888
  31. Lactacystin, proteasome function, and cell fate.
    J Biol Chem. 1998 Apr 10;273(15):8545-8 PMID: 9535824
  32. Post-transcriptional induction of p21cip1 protein in condylomata and dysplasias is inversely related to human papillomavirus activities.
    Am J Pathol. 1998 Apr;152(4):1015-24 PMID: 9546362
  33. Inhibitory function of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control.
    Science. 1998 May 15;280(5366):1069-72 PMID: 9582119
  34. The regulation of E2F by pRB-family proteins.
    Genes Dev. 1998 Aug 1;12(15):2245-62 PMID: 9694791
  35. Functional interaction between the bovine papillomavirus virus type 1 replicative helicase E1 and cyclin E-Cdk2.
    J Virol. 1998 Sep;72(9):7255-62 PMID: 9696820
  36. Induction of differentiation in normal human keratinocytes by adenovirus-mediated introduction of the eta and delta isoforms of protein kinase C.
    Mol Cell Biol. 1998 Sep;18(9):5199-207 PMID: 9710604
  37. Human papillomavirus oncoproteins alter differentiation-dependent cell cycle exit on suspension in semisolid medium.
    Virology. 1998 Oct 10;250(1):19-29 PMID: 9770416
  38. Post-transcriptional induction of p21cip1 protein by human papillomavirus E7 inhibits unscheduled DNA synthesis reactivated in differentiated keratinocytes.
    Oncogene. 1998 Oct 22;17(16):2027-38 PMID: 9798674
  39. Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle.
    Oncogene. 1998 Nov 19;17(20):2637-43 PMID: 9840927
  40. Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins.
    Oncogene. 1998 Nov 26;17(21):2787-98 PMID: 9840943
  41. Mutational analyses of differentiation-dependent human papillomavirus type 18 enhancer elements in epithelial raft cultures of neonatal foreskin keratinocytes.
    Cell Growth Differ. 1997 Jul;8(7):751-62 PMID: 9218869
  42. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein.
    Genes Dev. 1997 Aug 15;11(16):2090-100 PMID: 9284048
  43. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2.
    Genes Dev. 1997 Aug 15;11(16):2101-11 PMID: 9284049
  44. S-Phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation.
    Curr Biol. 1997 Sep 1;7(9):709-12 PMID: 9285720
  45. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
    EMBO J. 1997 Sep 1;16(17):5322-33 PMID: 9311992
  46. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
    EMBO J. 1997 Sep 1;16(17):5334-44 PMID: 9311993
  47. The cyclin-dependent kinase inhibitor p21cip1 mediates the growth inhibitory effect of phorbol esters in human venous endothelial cells.
    J Biol Chem. 1997 Nov 21;272(47):29967-74 PMID: 9368076
  48. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2.
    Biochem Biophys Res Commun. 1997 Nov 17;240(2):386-90 PMID: 9388487
  49. Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication.
    Mol Cell Biol. 1998 Jan;18(1):629-43 PMID: 9418909
  50. Viral E6-E7 transcription in the basal layer of organotypic cultures without apparent p21cip1 protein precedes immortalization of human papillomavirus type 16- and 18-transfected human keratinocytes.
    J Virol. 1998 Jan;72(1):749-57 PMID: 9420282
  51. Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein.
    Cell Growth Differ. 1997 Dec;8(12):1277-86 PMID: 9419416
  52. Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis.
    Virology. 1997 Dec 8;239(1):97-107 PMID: 9426450
  53. Retinoblastoma protein recruits histone deacetylase to repress transcription.
    Nature. 1998 Feb 5;391(6667):597-601 PMID: 9468139
  54. Cell transformation by the E7 oncoprotein of human papillomavirus type 16: interactions with nuclear and cytoplasmic target proteins.
    Adv Cancer Res. 2000;78:1-29 PMID: 10547667
  55. The role of the E6-p53 interaction in the molecular pathogenesis of HPV.
    Oncogene. 1999 Dec 13;18(53):7690-700 PMID: 10618709
  56. HeLa cells are phenotypically limiting in cyclin E/CDK2 for efficient human papillomavirus DNA replication.
    J Biol Chem. 2000 Mar 3;275(9):6167-74 PMID: 10692408
  57. Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases.
    Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4291-6 PMID: 10760295
  58. Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway.
    Mol Cell Biol. 2000 May;20(10):3497-509 PMID: 10779339
  59. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication.
    EMBO J. 2000 May 2;19(9):2069-81 PMID: 10790373
  60. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis.
    J Natl Cancer Inst. 2000 May 3;92(9):690-8 PMID: 10793105
  61. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination.
    Mol Cell. 2000 Feb;5(2):403-10 PMID: 10882081
  62. Leaky scanning is the predominant mechanism for translation of human papillomavirus type 16 E7 oncoprotein from E6/E7 bicistronic mRNA.
    J Virol. 2000 Aug;74(16):7284-97 PMID: 10906182
  63. Casein kinase II phosphorylation of the human papillomavirus-18 E7 protein is critical for promoting S-phase entry.
    Cell Growth Differ. 2000 Aug;11(8):425-35 PMID: 10965847
  64. Human Cdc7-related kinase complex. In vitro phosphorylation of MCM by concerted actions of Cdks and Cdc7 and that of a criticial threonine residue of Cdc7 bY Cdks.
    J Biol Chem. 2000 Sep 15;275(37):29042-52 PMID: 10846177
  65. NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription.
    Genes Dev. 2000 Sep 15;14(18):2283-97 PMID: 10995386
  66. Cell cycle-regulated phosphorylation of p220(NPAT) by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription.
    Genes Dev. 2000 Sep 15;14(18):2298-313 PMID: 10995387
  67. Improved retroviral vectors for gene transfer and expression.
    Biotechniques. 1989 Oct;7(9):980-2, 984-6, 989-90 PMID: 2631796
  68. Rottlerin, a novel protein kinase inhibitor.
    Biochem Biophys Res Commun. 1994 Feb 28;199(1):93-8 PMID: 8123051
  69. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA.
    Nature. 1994 Jun 16;369(6481):574-8 PMID: 7911228
  70. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase.
    Cell. 1994 Jul 15;78(1):161-72 PMID: 8033208
  71. Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme.
    Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8655-9 PMID: 7915843
  72. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.
    Science. 1995 Feb 17;267(5200):1018-21 PMID: 7863327
  73. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells.
    Science. 1995 Feb 17;267(5200):1024-7 PMID: 7863329
  74. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA.
    Nature. 1995 Mar 23;374(6520):386-8 PMID: 7885482
  75. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition.
    Mol Cell Biol. 1995 May;15(5):2612-24 PMID: 7739542
  76. Specific protein kinase C isozymes mediate the induction of keratinocyte differentiation markers by calcium.
    Cell Growth Differ. 1995 Feb;6(2):149-57 PMID: 7756173
  77. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.
    Genes Dev. 1995 Apr 15;9(8):935-44 PMID: 7774811
  78. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism.
    Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5545-9 PMID: 7777546
  79. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.
    Science. 1995 Aug 4;269(5224):682-5 PMID: 7624798
  80. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control.
    Cell. 1995 Aug 25;82(4):675-84 PMID: 7664346
  81. Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation.
    J Virol. 1995 Oct;69(10):6389-99 PMID: 7666540
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2001-07-00
Pages
6121-34
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC114328
Subset
IM
Grants
NCI NIH HHS · R01 CA036200 · United States
NCI NIH HHS · CA36200 · United States
NIDCR NIH HHS · DE/CA 11910 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com